Amylyx Pharmaceuticals Inc (NAS:AMLX) Stock News, Headlines & Updates
Amylyx Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 10, 2024
Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
Business Wire • 7:00am
Jul 09, 2024
Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide
Business Wire • 4:00pm
Jun 04, 2024
Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 9:00am
May 10, 2024
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
GuruFocus Research • 1:54pm
May 08, 2024
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
Business Wire • 9:00am
May 02, 2024
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
Business Wire • 9:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news